AIM ImmunoTech Langfristige Verbindlichkeiten 2011-2026 | AIM

Langfristige Verbindlichkeiten Jährlich AIM ImmunoTech

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	6.18 M	3.38 M	2.8 M	940 K	-	-	37 K	350 K	479 K

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert	Mindestwert	Durchschnitt
6.18 M	37 K	2.02 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name	Langfristige Verbindlichkeiten	Preis	% 24h	Marktkapitalisierung	Land
ADMA Biologics ADMA	99.5 M	$ 16.54	0.98 %	$ 3.94 B	USA
MorphoSys AG MOR	40.2 M	-	2.43 %	$ 254 M	Germany
Acer Therapeutics ACER	244 K	-	2.71 %	$ 14 M	USA
Acorda Therapeutics ACOR	257 M	-	-24.86 %	$ 820 K	USA
AgeX Therapeutics AGE	1.53 M	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	4.74 M	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	4.15 M	-	-	$ 26.5 M	USA
Apellis Pharmaceuticals APLS	289 M	$ 19.86	-	$ 2.51 B	USA
Aptorum Group Limited APM	2.21 M	$ 0.83	4.19 %	$ 4.53 M	China
AbCellera Biologics ABCL	326 M	$ 3.63	-2.16 %	$ 1.08 B	Canada
I-Mab IMAB	131 M	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	4.83 B	-	-	$ 40.3 B	USA
Biophytis SA BPTS	2.02 M	-	-13.47 %	$ 169 M	France
EyeGate Pharmaceuticals, Inc. EYEG	6.39 M	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	110 K	-	-18.52 %	$ 27.3 M	Britain
Akero Therapeutics AKRO	1.52 M	-	-	$ 3.67 B	USA
Akouos AKUS	12 M	-	0.23 %	$ 488 M	USA
Alpine Immune Sciences ALPN	15.9 M	-	-	$ 2.17 B	USA
AlloVir ALVR	5.46 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	3.53 M	-	-11.43 %	$ 502 K	USA
ANI Pharmaceuticals ANIP	182 M	$ 76.53	0.57 %	$ 1.48 B	USA
Applied Therapeutics APLT	797 K	-	-	$ 8.42 M	USA
Aravive ARAV	10.2 M	-	-13.39 %	$ 1.45 M	USA
Adverum Biotechnologies ADVM	27.3 M	-	-	$ 86.2 M	USA
Институт стволовых клеток человека ISKJ	541 M	-	-	-	Russia
Athersys ATHX	5.4 M	-	3.77 %	$ 22.4 M	USA
ARCA biopharma ABIO	409 K	-	1052.0 %	$ 415 M	USA
AVEO Pharmaceuticals AVEO	14.7 M	-	-	$ 521 M	USA
Axsome Therapeutics AXSM	48.9 M	$ 164.08	0.02 %	$ 8.16 B	USA
Champions Oncology CSBR	1 M	$ 6.0	-	$ 82 M	USA
BridgeBio Pharma BBIO	97.6 M	$ 66.54	3.11 %	$ 12.7 B	USA
Brainstorm Cell Therapeutics BCLI	618 K	-	-2.5 %	$ 5.88 M	USA
BioDelivery Sciences International BDSI	78.7 M	-	-4.8 %	$ 255 M	USA
Acasti Pharma ACST	12.2 M	-	4.01 %	$ 150 M	Canada
BeiGene, Ltd. BGNE	2 B	-	0.49 %	$ 251 B	Cayman-islands
Bellicum Pharmaceuticals BLCM	48 M	-	-9.72 %	$ 5.89 M	USA
Berkeley Lights BLI	22.3 M	-	-7.31 %	$ 87 M	USA
CureVac N.V. CVAC	112 M	-	-	$ 867 M	Germany
Aeterna Zentaris AEZS	19.1 M	-	5.93 %	$ 314 M	Canada
Bellerophon Therapeutics BLPH	1.93 M	-	-74.18 %	$ 955 K	USA
BioLineRx Ltd. BLRX	8.22 M	$ 2.81	-	$ 908 M	Israel
BioMarin Pharmaceutical BMRN	635 M	$ 60.43	3.25 %	$ 11.6 B	USA
Cabaletta Bio CABA	43.9 M	$ 3.43	5.54 %	$ 4.01 M	USA
AIkido Pharma AIKI	2.29 M	-	1.93 %	$ 17.4 M	USA
Agenus AGEN	264 M	$ 3.2	0.63 %	$ 1.15 M	USA
Ayala Pharmaceuticals AYLA	553 K	-	-	$ 7.46 M	Israel
Capricor Therapeutics CAPR	4.86 M	$ 25.5	-1.32 %	$ 683 M	USA
Agios Pharmaceuticals AGIO	157 M	$ 28.19	-1.02 %	$ 1.63 B	USA
CymaBay Therapeutics CBAY	1.26 M	-	-	$ 3.45 B	USA